Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have been assigned a consensus recommendation of “Strong Buy” from the five analysts that are presently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a strong buy recommendation.
HIV has been the topic of a number of analyst reports. Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Finally, Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, March 7th.
View Our Latest Stock Analysis on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- Investing In Preferred Stock vs. Common Stock
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Overbought Stocks Explained: Should You Trade Them?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Invest in the FAANG Stocks
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
